Divine E Ediebah
Overview
Explore the profile of Divine E Ediebah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kereiakes D, Ellis S, Metzger D, Caputo R, Rizik D, Teirstein P, et al.
Circulation
. 2019 Sep;
140(23):1895-1903.
PMID: 31553222
Background: The Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) provides early drug delivery and mechanical support similar to those of metallic drug-eluting stents, followed by complete resorption in ≈3 years with...
2.
Ediebah D, Quinten C, Coens C, Ringash J, Dancey J, Zikos E, et al.
Cancer
. 2018 Jun;
124(16):3409-3416.
PMID: 29905936
Background: The aims of this study were to externally validate an established association between baseline health-related quality of life (HRQOL) scores and survival and to assess the added prognostic value...
3.
Ediebah D, Reijneveld J, Taphoorn M, Coens C, Zikos E, Aaronson N, et al.
Qual Life Res
. 2016 Oct;
26(4):869-880.
PMID: 27744512
Purpose: Clinical trials in glioma patients with neurocognitive deficits face challenges due to lacking or unreliable patient self-reports on their health-related quality of life (HRQOL). Patient-proxy data could help solve...
4.
Zikos E, Coens C, Quinten C, Ediebah D, Martinelli F, Ghislain I, et al.
J Natl Cancer Inst
. 2015 Dec;
108(5).
PMID: 26714759
Background: The European Organisation for Research and Treatment of Cancer (EORTC) Patient-Reported Outcomes and Behavioural Evidence (PROBE) initiative was established to investigate critical topics to better understand health-related quality of...
5.
Quinten C, Coens C, Ghislain I, Zikos E, Sprangers M, Ringash J, et al.
Eur J Cancer
. 2015 Nov;
51(18):2808-19.
PMID: 26602015
Background: Cancer incidence increases exponentially with advancing age, cancer patients live longer than in the past, and many new treatments focus on stabilizing disease and HRQOL. The objective of this...
6.
Ediebah D, Galindo-Garre F, Uitdehaag B, Ringash J, Reijneveld J, Dirven L, et al.
Qual Life Res
. 2014 Oct;
24(4):795-804.
PMID: 25311306
Purpose: In cancer research, outcome measures may co-vary. Treatment and treatment related impairment of health-related quality of life (HRQoL) may affect survival. When these effects are analyzed separately, bias may...
7.
Zikos E, Ghislain I, Coens C, Ediebah D, Sloan E, Quinten C, et al.
Lancet Oncol
. 2014 Feb;
15(2):e78-89.
PMID: 24480558
Small-cell lung cancer represents about 15% of all lung cancers; increasingly, randomised controlled trials of this disease measure the health-related quality of life of patients. In this Systematic Review we...
8.
Quinten C, Martinelli F, Coens C, Sprangers M, Ringash J, Gotay C, et al.
Cancer
. 2013 Oct;
120(2):302-11.
PMID: 24127333
Background: The objective of this study was to examine the prognostic value of baseline health-related quality of life (HRQOL) for survival with regard to different cancer sites using 1 standardized...